<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">3557282</PMID>
        <DateCompleted>
            <Year>1987</Year>
            <Month>05</Month>
            <Day>11</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2015</Year>
            <Month>11</Month>
            <Day>19</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0018-5043</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>19</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>1987</Year>
                        <Month>Jan</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme</Title>
                <ISOAbbreviation>Horm Metab Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The nonsuppressibility of plasma cortisol persists after pregnancy.</ArticleTitle>
            <Pagination>
                <MedlinePgn>41-2</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>To determine if normal balance is restored to the hypothalamic-pituitary-adrenal axis after pregnancy, we compared the dexamethasone suppressibility of plasma cortisol in women four days after delivery of their infant, with that of nonpregnant women. Plasma concentrations of cortisol before dexamethasone administration were similar in the post-partum women and in women taking oestrogen contraceptives, but both were higher than in normally cycling women. After dexamethasone, plasma cortisol in the post-partum women was significantly higher than in both oestrogen-taking and normally cycling nonpregnant women. The reduced dexamethasone-suppressibility of plasma cortisol, which is characteristic of pregnancy, extends into the post-partum period.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Smith</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Owens</LastName>
                    <ForeName>P C</ForeName>
                    <Initials>PC</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brinsmead</LastName>
                    <ForeName>M W</ForeName>
                    <Initials>MW</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Singh</LastName>
                    <ForeName>B</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hall</LastName>
                    <ForeName>C</ForeName>
                    <Initials>C</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Horm Metab Res</MedlineTA>
            <NlmUniqueID>0177722</NlmUniqueID>
            <ISSNLinking>0018-5043</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D003276">Contraceptives, Oral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>423D2T571U</RegistryNumber>
                <NameOfSubstance UI="D004997">Ethinyl Estradiol</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>7S5I7G3JQL</RegistryNumber>
                <NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>WI4X0X7BPJ</RegistryNumber>
                <NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <CitationSubset>J</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D003276" MajorTopicYN="N">Contraceptives, Oral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003907" MajorTopicYN="Y">Dexamethasone</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004997" MajorTopicYN="N">Ethinyl Estradiol</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D049590" MajorTopicYN="N">Postpartum Period</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <OtherID Source="PIP">044182</OtherID>
        <OtherID Source="POP">00171526</OtherID>
        <OtherAbstract Type="PIP" Language="eng">
            <AbstractText>To determine whether normal balance is restored to the hypothalamic-pituitary-adrenal axis after pregnancy, the dexamethasone suppressibility of plasma cortisol in 7 women 4 days after delivery was compared with that in 15 nonpregnant women (10 of whom who were using oral contraceptives).  The plasma concentrations of cortisol before dexamethasone administration in the postpartum women were not significantly different from those of normal nonpregnant women ingesting estrogen-based oral contraceptives; however, both these groups had higher pre-dexamethasone concentrations of cortisol than the group of normal cycling women not taking oral contraceptives.  Dexamethasone reduced the plasma total in all women, but plasma cortisol after dexamethasone was significantly higher in the postpartum group than in nonpregnant women.  The observed persistence of dexamethasone resistance for at least 4 days after removal of the placenta argues against a glucocorticoid-resistant placental stimlus acting at the level of the adrenal.  Antagonism of glucocorticoid inhibition at the pituitary or hypothalamus by progesterone would also appear to be ruled out by the demonstration of persistence of dexamethasone resistance after pregnancy, at a time when plasma progesterone has returned to nonpregnant levels.  On the other hand, it is possible that progesterone may still occupy cortisol receptors 4 days postpartum.</AbstractText>
        </OtherAbstract>
        <KeywordList Owner="PIP">
            <Keyword MajorTopicYN="N">Biology</Keyword>
            <Keyword MajorTopicYN="Y">Central Nervous System</Keyword>
            <Keyword MajorTopicYN="Y">Comparative Studies</Keyword>
            <Keyword MajorTopicYN="Y">Dexamethasone Acetate</Keyword>
            <Keyword MajorTopicYN="Y">Endocrine System</Keyword>
            <Keyword MajorTopicYN="Y">Hormones</Keyword>
            <Keyword MajorTopicYN="Y">Hypothalamus</Keyword>
            <Keyword MajorTopicYN="Y">Physiology</Keyword>
            <Keyword MajorTopicYN="Y">Pituitary Gland</Keyword>
            <Keyword MajorTopicYN="Y">Postpartum Women</Keyword>
            <Keyword MajorTopicYN="Y">Pregnancy</Keyword>
            <Keyword MajorTopicYN="N">Puerperium</Keyword>
            <Keyword MajorTopicYN="Y">Reproduction</Keyword>
            <Keyword MajorTopicYN="N">Research Methodology</Keyword>
            <Keyword MajorTopicYN="N">Studies</Keyword>
        </KeywordList>
        <GeneralNote Owner="PIP">TJ: HORMONE AND METABOLIC RESEARCH.</GeneralNote>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>1987</Year>
                <Month>1</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>1987</Year>
                <Month>1</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>1987</Year>
                <Month>1</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">3557282</ArticleId>
            <ArticleId IdType="doi">10.1055/s-2007-1011733</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
